farnesol and Leukemia, Lymphoblastic, Acute, T Cell

farnesol has been researched along with Leukemia, Lymphoblastic, Acute, T Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bortner, CD; Jetten, AM; Joo, JH; Liao, G; Ueda, E; Yang, XP	1

Other Studies

1 other study(ies) available for farnesol and Leukemia, Lymphoblastic, Acute, T Cell

Article	Year
Farnesol activates the intrinsic pathway of apoptosis and the ATF4-ATF3-CHOP cascade of ER stress in human T lymphoblastic leukemia Molt4 cells. Biochemical pharmacology, 2015, Oct-01, Volume: 97, Issue:3 Topics: Activating Transcription Factor 3; Activating Transcription Factor 4; Anticarcinogenic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Farnesol; Humans; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Transcription Factor CHOP; Transcriptome; Transfection	2015

Article

Year

Farnesol activates the intrinsic pathway of apoptosis and the ATF4-ATF3-CHOP cascade of ER stress in human T lymphoblastic leukemia Molt4 cells.

Biochemical pharmacology, 2015, Oct-01, Volume: 97, Issue:3

Topics: Activating Transcription Factor 3; Activating Transcription Factor 4; Anticarcinogenic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Farnesol; Humans; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Transcription Factor CHOP; Transcriptome; Transfection

2015